Northeast Epi

Northeast Epi, LLC is a specialized epidemiology and life sciences consulting firm headquartered in Bradford, New Hampshire. The company provides expert support to biotechnology and pharmaceutical firms in areas such as real-world evidence (RWE) generation, study design, and commercial due diligence. Northeast Epi is particularly active in rare disease research, having contributed to significant studies on Lambert-Eaton myasthenic syndrome (LEMS) and Duchenne muscular dystrophy (DMD) in collaboration with industry partners like Catalyst Pharmaceuticals. Their service portfolio includes data analysis, literature reviews, market model development, and the creation of clinical trial benchmarking tools. Led by experienced epidemiologists, the firm helps clients translate complex health data into actionable strategic insights for product development and market access.